Grant of Options to Directors

RNS Number : 6584S
NetScientific PLC
26 June 2018
 

 

 

 ("NetScientific" or the "Company" or the "Group")

 

NetScientific plc

 

Grant of Options to Directors

 

London, UK - 26th June 2018 - NetScientific plc (AIM:NSCI) (the "Company"), the transatlantic healthcare IP commercialisation Group, today announced that on 21st June 2018, options over ordinary shares of 5p each were granted to its CEO François Martelet and CFO Ian Postlethwaite as detailed below (the "New Options").

 

Director

Number of Options Granted

Total Number of Options Held

Francois Martelet

300,000

1,059,020

Ian Postlethwaite

200,000

560,000

 

The New Options have an exercise price of 45.5 pence per share, being the average closing price for the ordinary shares over the five dealing days prior to the date on which the options were granted. The New Options vest three years from the date of grant.

 

For more information, please contact:

 

  NetScientific

  François R. Martelet, M.D., CEO

  Ian Postlethwaite, CFO

 

Tel: +44 (0)20 3514 1800

 Consilium Strategic Communications

  Mary-Jane Elliott Jessica Hodgson /

  Chris Welsh / Laura Thornton 

 

Tel: +44 (0)20 3709 5700

netscientific@consilium-comms.com

Stifel Nicolaus Europe Limited (NOMAD and Broker)

Jonathan Senior / David Arch / Ben Maddison

 

 

 Tel: +44 (0) 20 7710 7600

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on the grant of options to PDMRs.

  

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 Francois Martelet

2

Reason for the notification

a)

Position/status

 CEO, NetScientific plc

b)

Initial notification/ Amendment

 Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

NetScientific plc

b)

LEI

213800N5WD46G1Y7I458

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Option over Ordinary Shares

 

 ISIN for NetScientific plc Ordinary Shares: GB00B9F4MT28

 

b)

Nature of the transaction

Grant of option

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 £0.455

 300,000

 

d)

Aggregated information

-      Aggregated volume

-      Price

 

300,000

£0.455

e)

Date of the transaction

21 June 2018

f)

Place of the transaction

Off market

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

 Ian Postlethwaite

2

Reason for the notification

a)

Position/status

 CFO, NetScientific plc

b)

Initial notification/ Amendment

 Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

NetScientific plc

b)

LEI

213800N5WD46G1Y7I458

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Option over Ordinary Shares

 

 ISIN for NetScientific plc Ordinary Shares: GB00B9F4MT28

 

b)

Nature of the transaction

Grant of option

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 £0.455

 200,000

 

d)

Aggregated information

-      Aggregated volume

-      Price

 

200,000

£0.455

e)

Date of the transaction

21 June 2018

f)

Place of the transaction

Off market

 

 

About NetScientific

 

NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHMMGZVKVRGRZM

Companies

Emv Capital (EMVC)
UK 100

Latest directors dealings